Aducanumab: A Deep Dive into BIIB037 and its Impact This compound, previously known as BIIB037, is a significant attempt to combat emerging Alzheimer's condition. Designed by Biogen, aducanumab acts by targeting https://georgiajhrf394661.blognody.com/50469611/text